about
T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and OpportunitiesPeptide vaccination therapy: Towards the next generation.Implication of chemo-resistant memory T cells for immune surveillance in patients with sarcoma receiving chemotherapy.Potential mechanisms underlying CDK5 related Osteosarcoma progression.Irradiation enhanced the effects of PD-1 blockade in brain metastatic osteosarcoma.
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The future of immunotherapy for sarcoma.
@en
type
label
The future of immunotherapy for sarcoma.
@en
prefLabel
The future of immunotherapy for sarcoma.
@en
P2093
P2860
P1476
The future of immunotherapy for sarcoma.
@en
P2093
Emi Mizushima
Kenji Murata
Makoto Emori
Noriyuki Sato
Takayuki Kanaseki
Terufumi Kubo
Tomohide Tsukahara
Toshihiko Torigoe
Toshihiko Yamashita
Yoshihiko Hirohashi
P2860
P304
P356
10.1080/14712598.2016.1188075
P407
P577
2016-05-09T00:00:00Z